Production of recombinant mink growth hormone in E. coli

Jolanta Sereikaite1, Alina Statkute, Mindaugas Morkunas

  • 1Department of Chemistry and Bioengineering, Faculty of Fundamental Sciences, Vilnius Gediminas Technical University, Sauletekio al. 11, 2040 Vilnius, Lithuania. sjolanta@fm.vtu.lt

Insights

Researchers developed a method to produce large quantities of mink growth hormone (mGH) using Escherichia coli. This method yields highly purified and biologically active mGH, enabling further scientific investigation.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Protein Expression

Background:

  • Mink growth hormone (mGH) is crucial for animal growth and development.
  • Efficient production of recombinant mGH is essential for research and potential applications in the fur industry.

Purpose of the Study:

  • To develop a scalable and efficient method for producing recombinant mink growth hormone (mGH) in Escherichia coli.
  • To optimize expression conditions and purification strategies for high-yield production of active mGH.

Main Methods:

  • Escherichia coli cells were engineered to express mink growth hormone (mGH).
  • Batch fermentation was employed to culture the engineered E. coli.
  • Recombinant mGH was induced using isopropyl β-D-thiogalactoside (IPTG) at varying concentrations (1 mM and 0.2 mM).
  • Inclusion bodies containing mGH were solubilized in 8 M urea and renatured via a dilution protocol.
  • A two-step purification process involving ion-exchange chromatography (Q-Sepharose) and hydrophobic interaction chromatography (Phenyl-Sepharose) was utilized.

Main Results:

  • Expression levels of mGH reached 27% of total cellular protein with 1 mM IPTG induction after 3 hours.
  • Slightly lower expression (23%) was observed with 0.2 mM IPTG.
  • Purification yielded 25-30 mg of highly purified and biologically active mGH from 4 g of biomass.
  • The renaturation protocol was effective at protein concentrations of 1.4-2.1 mg/ml using a glutathione redox buffer ([GSH]/[GSSG] ratio of 2/1).

Conclusions:

  • A robust and scalable method for producing recombinant mink growth hormone (mGH) in E. coli has been established.
  • The developed purification strategy effectively yields highly purified and biologically active mGH.
  • This production method facilitates further in vivo studies on mGH effects in mink and supports its potential use in the fur industry.